Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "JOURNAL OF VIRUS ERADICATION"

Add to list
- Conference Paper
- C3
- open access
Long-read sequencing assay allows accurate characterization of the HIV-1 reservoir

Laurens Lambrechts (UGent) , Rita Verstraeten, Noah Bonine (UGent) , Ytse Noppe (UGent) , Sofie Rutsaert (UGent) , Marion Pardons (UGent) , Basiel Cole (UGent) and Linos Vandekerckhove (UGent)

(2022) JOURNAL OF VIRUS ERADICATION. In Journal of Virus Eradication 8(Supplement S). p.18-19
Add to list
- Conference Paper
- C3
- open access
Characterization of the HIV-1 viral reservoir in subtype B early treated individuals

Tine Struyve (UGent) , Marion Pardons (UGent) , Liesbet Termote (UGent) , Jozefien De Clercq (UGent) , Laurens Lambrechts (UGent) , Jerel Vega, Daniel Boden, Mathias Lichterfeld, Sofie Rutsaert (UGent) and Linos Vandekerckhove (UGent)

(2022) JOURNAL OF VIRUS ERADICATION. In Journal of Virus Eradication 8(Supplement S). p.46-46
Add to list
- Journal Article
- A1
- open access
Motivations, barriers and experiences of participants in an HIV reservoir trial

Marie-Angélique De Scheerder (UGent) , Ward P.H. van Bilsen, Melissa Dullaers, Javier Martinez-Picado, Udi Davidovich and Linos Vandekerckhove (UGent)

(2021) JOURNAL OF VIRUS ERADICATION. 7(1).
Add to list
- Miscellaneous
- open access
HIV cure research in the time of COVID-19 : antiretroviral therapy treatment interruption trials : a discussion paper

S. Fidler, S. Lewin, S. Deeks, O. S. Sogaard, Linos Vandekerckhove (UGent) , S. Collins, D. Kelly, J. Singh, M. Caskey and J. Frater

(2021) JOURNAL OF VIRUS ERADICATION. 7(1).
Add to list
- Miscellaneous
- open access
Launching a multidisciplinary European collaboration towards a cure for HIV : the EU2Cure Consortium

C. Rokx, H. A. B. Prins, Linos Vandekerckhove (UGent) , S. J. Fidler, J. Frater, M. Bracchi, O. S. Sogaard, M. Tolstrop, T. A. Rasmussen, M. Salgado, et al.

(2021) JOURNAL OF VIRUS ERADICATION. 7(2).
Add to list
- Journal Article
- A1
- open access
Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1 : a Phase IIa randomised controlled study

Sofie Rutsaert (UGent) , Jean-Marc Steens, Paul Gineste, Basiel Cole (UGent) , Sam Kint, P Noel Barrett, Jamal Tazi, Didier Scherrer, Hartmut J Ehrlich and Linos Vandekerckhove (UGent)

(2019) JOURNAL OF VIRUS ERADICATION. 5(1). p.10-22
Add to list
- Journal Article
- A1
- open access
Establishment of latent HIV-1 reservoirs : what do we really know?

Jef Vanhamel (UGent) , Anne Bruggemans and Zeger Debyser

(2019) JOURNAL OF VIRUS ERADICATION. 5(1). p.3-9
Add to list
- Miscellaneous
- open access
Highlights from the HIV Cure and Reservoir Symposium, 11-12 September 2017, Ghent, Belgium

Sam Kint, Clarissa Van Hecke, Basiel Cole (UGent) , Linos Vandekerckhove (UGent) and Magdalena Sips (UGent)

(2018) JOURNAL OF VIRUS ERADICATION. 4(1). p.55-58
Add to list
- Miscellaneous
- open access
Highlights from the 9th IAS conference on HIV science, 23-26 July 2017, Paris, France

Christina K Psomas, Tristan J Barber, Sofie Rutsaert (UGent) and Sabine Kinloch-de Loës

(2017) JOURNAL OF VIRUS ERADICATION. 3(4). p.242-249
Add to list
- Journal Article
- A1
- open access
Highlights from the 24th conference on retroviruses and opportunistic infections, 13-16 February 2017, Seattle, Washington, USA

Trevor A Crowell, Hermione Lyall, Eva Malatinková (UGent) , Sanjay Bhagani, Denise Hsu, Donn J Colby, Christina Polyak, Christina Psomas, Andrew Hill, Esther N Gathogo, et al.

(2017) JOURNAL OF VIRUS ERADICATION. 3(1). p.101-108

Academic Bibliography

Long-read sequencing assay allows accurate characterization of the HIV-1 reservoir

Characterization of the HIV-1 viral reservoir in subtype B early treated individuals

Motivations, barriers and experiences of participants in an HIV reservoir trial

HIV cure research in the time of COVID-19 : antiretroviral therapy treatment interruption trials : a discussion paper

Launching a multidisciplinary European collaboration towards a cure for HIV : the EU2Cure Consortium

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1 : a Phase IIa randomised controlled study

Establishment of latent HIV-1 reservoirs : what do we really know?

Highlights from the HIV Cure and Reservoir Symposium, 11-12 September 2017, Ghent, Belgium

Highlights from the 9th IAS conference on HIV science, 23-26 July 2017, Paris, France

Highlights from the 24th conference on retroviruses and opportunistic infections, 13-16 February 2017, Seattle, Washington, USA

Contents

Support

Contact